It’s October and time for flu shots. Medical experts urge getting a flu vaccination soon, before influenza starts spreading ...

Moderna (MRNA) skyrocketed to fame during the pandemic. Its Covid-19 vaccine put the biotech on the map, sent sales soaring, ...

A Delaware federal judge has rejected Moderna's argument that the US government's license to patents ​from federally funded research should shield the company ‌from allegations that vaccines sold to ...

Nasdaq-100 entry creates forced, short-term index demand, but Citi’s core point is still the thesis killer: valuation is stretched versus realistic oncology sales. The stock is already up 500% in 2026 ...

In a major update, a Delaware federal judge has rejected Moderna’s argument that a US government license stemming from ...

Fintel reports that on September 30, 2026, Citigroup downgraded their outlook for Moderna, Inc. - Depositary Receipt (BASE:MRNA) from Neutral to Sell. This rating action follows a prior action by ...

Companies striving to reduce continent’s reliance on foreign shots must overcome major financial and logistical challenges ...

Healthcare is a heavily regulated market and products will always be in demand. New technologies such as AI and genome ...

Oct 1 (Reuters) - Nasdaq said on Thursday that vaccine maker Moderna will replace Warner Bros. Discovery on the Nasdaq 100 ...